BG Medicine, Inc.
(Other OTC/NBB : BGMD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.32%72.110.9%$619.68m
CELGCelgene Corporation
0.06%127.651.1%$445.33m
AMGNAmgen Inc.
-0.31%167.291.1%$418.48m
BIIBBiogen Inc.
-0.93%281.771.2%$356.38m
REGNRegeneron Pharmaceuticals, Inc.
0.85%467.982.7%$321.83m
VRTXVertex Pharmaceuticals Incorporated
-0.28%148.131.9%$264.60m
ALXNAlexion Pharmaceuticals, Inc.
-0.91%133.401.9%$217.97m
ILMNIllumina, Inc.
-0.98%189.323.5%$216.35m
SRPTSarepta Therapeutics, Inc.
-0.46%36.7019.8%$138.44m
INCYIncyte Corporation
-0.45%121.192.6%$130.95m
CLVSClovis Oncology, Inc.
2.99%71.9618.0%$129.20m
KITEKite Pharma, Inc.
3.29%130.1816.1%$121.84m
TSROTESARO, Inc.
4.41%113.8614.7%$121.68m
AAgilent Technologies, Inc.
0.62%61.241.5%$119.01m
BMRNBioMarin Pharmaceutical Inc.
-0.07%80.924.4%$108.58m

Company Profile

BG Medicine, Inc. engages in the research and development, clinical research, manufacture and sale of diagnostic products for heart failure and related disorders. It distributes its products such as BGM Galectin-3 to clinical laboratories, hospitals and health care provider. The company was founded in February 2000 and is headquartered in Waltham, MA.